ABSTRACT
Introducao: Todos os servicos de saude foram impactados durante a pandemia de COVID-19, os servicos de hemoterapia, que dependem de doadores voluntarios, sofreram com a necessidade de isolamento da populacao e pelo medo do contagio ao vir doar, tambem por doadores infectados e maior numero de transfusoes em pacientes com complicacoes da COVID-19. As outras patologias com necessidade de transfusao ainda existiam e os bancos de sangue tiveram que se reorganizar para buscar ativamente os doadores e atender as medidas necessarias para evitar o contagio, como nao causar aglomeracoes, distanciamento entre as cadeiras do doador e uso de mascara e alcool gel. Objetivos: Avaliar o perfil do doador de sangue do servico de hemoterapia do Hospital Marcio Cunha durante o periodo critico da pandemia de COVID-19. Materiais e Metodos: estudo descritivo, retrospectivo e quantitativo, realizado no servico de hemoterapia atraves de avaliacao do relatorio de producao Hemoterapica - Hemoprod, dos meses de maio 2020 a julho 2021, periodo com elevado numero de obitos por COVID-19 no Brasil. Resultados e Discussao: Nos meses de maio/20 a julho/21 foram entrevistados 12.154 candidatos, sendo 9.449 aptos para doacao de sangue total, media de 629 doadores/mes. A maior parte das doacoes foi espontanea (55,6%), seguida de reposicao e apenas uma doacao autologa no periodo. Em relacao ao tipo de doador;69,7% doaram pela primeira vez;29,5% de forma esporadica e apenas 0,7% de repeticao. A maioria dos doadores foi do genero masculino (58,2%) com idade acima de 29 anos (67,7%). A principal causa da inaptidao na triagem foi descrito como outras (20%), sendo mais comum o uso de medicamentos que impedem a doacao e procedimentos endoscopicos nos ultimos seis meses;3,65% apresentavam hematocrito abaixo do necessario;2,8% hipotensao e 1,04% comportamento de risco para doenca sexualmente transmissivel. No que se refere a triagem sorologica, 221 doadores apresentaram sorologia positiva (2,3%) sendo 47% anti-HBc total reagente, 45.8% sifilis;2,7% anti-HCV;1,8% HBsAg e HTLV e 0,9% HIV. Quanto ao perfil imunohematologico 41,8% foram do grupo O positivo e 28,7% A positivo, sendo os mais frequentes e 9,9% foram O negativo. No periodo foram produzidos 9.323 concentrados de hemacias e transfundidos 6.826 e produzidos 8.948 concentrados de plaquetas e transfundidos 3.983. Conclusao: Nao ha substituto para sangue humano, por isso os servicos de hemoterapia dependem dos doadores voluntarios para manter o estoque de hemocomponentes. No periodo da pandemia houve menor numero de doacoes e maior necessidade de transfusoes em decorrencias das complicacoes da COVID-19. O banco de sangue do Hospital Marcio Cunha atendeu as medidas sanitarias para evitar o contagio e utilizou de estrategias de captacao de doares para tentar diminuir o impacto para o setor assistencial, no periodo analisado o numero de doacoes foi suficiente para atender a demanda transfusional, fato tambem relacionado a reducao de cirurgias eletivas. Copyright © 2022
ABSTRACT
Study question: Do the Merck family of fertility pen injectors (follitropinalfa, follitropin-alfa/lutropin-alfa, choriogonadotropin-alfa) meet the International Organization for Standardization (ISO 11608-1:2000/2012/ 2014) product-validation requirements? Summary answer: Each presentation of the family of fertility pen injectors performed as per the state-of-the-art product-validation specifications for dose accuracy in ISO 11608-1:2000/2012/2014 under atmospheric conditions. What is known already: Pen injectors for medically assisted reproduction must comply with ISO 11608-1:2000/2012/2014, which specifies essential performance requirements, including dose accuracy, and represent a benchmark for product reliability. Product-validation studies of the follitropin-alfa pen injector showed that three presentations (300 IU, 450 IU, and 900 IU) reliably dispensed accurate doses under a range of conditions, but no information was available for the follitropin-alfa/lutropin-alfa and choriogonadotropinalfa pen injectors. This study was done to confirm that the incremental dose/ clicks system was accurate for equivalence of volume (dose) delivered at standard atmospheric conditions for the complete Merck family of fertility pen injectors (follitropin-alfa, follitropin-alfa/lutropin-alfa, choriogonadotropin-alfa). Study design, size, duration: Laboratory-based dose accuracy measurement testing was carried out under standard atmospheric conditions, as specified in ISO 11608-1:2000/2012/2014, between 2015 and 2020. Participants/materials, setting, methods: Set doses (Vset) for three dose dial settings (minimum dose [Vmin], midpoint dose [Vmid] and maximum dose [Vmax] [follitropin-alfa, choriogonadotropin-alfa, and follitropinalfa/ lutropin-alfa]) or a single Vset (choriogonadotropin-alfa) were assessed, as appropriate. The last dose administered by the multi-dose device and cartridge and total extractable dose were assessed on the 900 IU and 300 IU follitropin- alfa and the 900 IU/450IU and 300/150 IU follitropin-alfa/lutropinalfa- pen presentations. Sixty measurements per assessment were made for each Vset. Main results and the role of chance: Measurements were performed at two manufacturing sites. Dose accuracy tests for Vmin, Vmid and Vmax (dose dial settings of 12.5 IU, 87.5 IU and 150 IU, respectively, for the 150 IU pen [n=2,226 (one site)];dose dial settings of 12.5 IU, 162.5 IU and 300 IU, respectively, for the 300 IU pen [n=742 per site];and dose dial settings of 12.5 IU, 237.5 IU and 450 IU, respectively, for the 450 IU [n=180 per site] and 900 IU pens [n=410 per site]) for the follitropin-alfa and the follitropinalfa/ lutropin-alfa pen injectors were within the acceptable limits defined in ISO 11608-1:2000/2012/2014. The results of further assessments of last dose and total extracted volume for each presentation of these devices were also within acceptable limits. Dose accuracy tests for the single use/single dose device classification (D1) of the choriogonadotropin-alfa pen injector (n=210 [one site]) showed that the Vset (6,500 IU) was within the acceptable limits according to ISO 11608-1:2000/2012/2014. Furthermore, dose accuracy tests for the single use/variable dose device classification (D2) of the choriogonadotropin-alfa pen injector (n=180 [one site]) showed that the Vmin (260 IU), Vmid (3,380 IU) and Vmax (6,500 IU) values were also the within acceptable limits. Limitations, reasons for caution: These assessments were carried out by laboratory scientists, who are not the intended users of the pen injectors, and were not delivered into human tissue;therefore, although these conditions meet the international standards, they do not reflect the real-world use of the pen injectors by patients. Wider implications of the findings: The Merck family of fertility pen injectors functions reliably and the incremental dose/clicks system dispenses accurate doses, providing users with confidence that they can accurately administer the prescribed dose and minimize drug wastage outside of a clinic environment, which is ore important than ever in light of the COVID pandemic.
ABSTRACT
The report presented here aims to report the experience of two academics who participated in the extension project "Virtual Health: prevention within your home". Methodology: This is a descriptive study of qualitative nature in the modality of experience report conducted by two undergraduates of the nursing course as scholarship holders of the project during the months of April to July 2020. Result and discussion: The project was interesting and innovative for students and the community, as it allowed scholars and professionals to pass on to people in a dynamic and virtual way the information about the new coronavirus. Final Considerations: The project has become an indispensable and important tool in the life of every Tocantin. citizen who visited the project's communication channels, as they can now be a source of information about the disease for family members and colleagues.
ABSTRACT
O Grupo GSH, para garantir o cumprimento de sua missão: “Prover Soluções em Hemoterapia com Excelência, Segurança e Inovação”, adotou como estratégia a aquisição do Selo COVID FREE por meio da implantação e adequação de práticas preventivas para o enfrentamento do Coronavírus. O Grupo encontra-se atualmente em 16 Estados, com 06 Centros de Produção certificados com o Selo COVID FREE e mais de 120 Agências Transfusionais que prestam assistência hemoterápica para mais de 240 hospitais e clínicas. Diante do crescimento do Grupo, entende-se que a Equipe de Qualidade é de suma importância à medida que oferece suporte contínuo durante o processo de certificação e manutenção das diretrizes e boas práticas de gerenciamento de riscos e gestão. Objetivo: O principal objetivo deste artigo é demonstrar quantitativamente e qualitativamente os benefícios da implantação e acompanhamento das boas práticas preventivas para o enfrentamento do Coronavírus pela Certificação COVID FREE. Material e método: Para desenvolvimento deste artigo, utilizamos dados coletados da plataforma BE SOLUTIONS-COVID FREE, Sistema de Gestão da Qualidade AS – Strategic Adviser, treinamentos, Pesquisa de Cultura de Segurança/Clima Organizacional e Auditorias Internas realizadas pela equipe da Qualidade. Resultados: Após implantação da Certificação COVID FREE nos Centros de Produção, foi evidenciado mesmo durante os períodos mais críticos da Pandemia COVID-19 a manutenção dos níveis de satisfação dos doadores com média de 98, 33% e em relação aos pacientes a média foi de 99,72%. É importante ressaltar que para avaliar a satisfação dos colaboradores foi realizada uma Pesquisa de Cultura de Segurança/Clima Organizacional com média de satisfação de 93%. Discussão: No segundo semestre de 2021 foi iniciado o processo de implantação e adequação das boas práticas de segurança para o enfrentamento do Coronavírus nos Centros de Produção do Grupo GSH, conforme os padrões estabelecidos no Manual de Certificação COVID FREE. Durante a implantação seguimos as seguintes etapas: 1. Diagnóstico: Autoavaliação das unidades. 2. Implantação: Sensibilização dos colaboradores e adequação das práticas de segurança através do distanciamento físico, higienização e limpeza, utilização de equipamentos de proteção, monitoramento de saúde física e mental dos colaboradores, elaboração de informativos específicos de prevenção e controle, treinamentos, fortalecimento da comunicação efetiva elaboração de planos de contingência, dentre outros. Posteriormente foi realizado o upload das evidências, conforme requisitos do manual na Plataforma IBES Digital. 3. Certificação: Os avaliadores validaram as evidências, por meio da análise de documentos, entrevistas e fotos. Após avaliação emitiram o certificado aos Centros de Produção contemplados no escopo da Certificação. Conclusão: A implantação da Certificação foi de grande valia para o Grupo GSH, pois auxiliou na manutenção de um ambiente seguro conferindo credibilidade em relação as boas práticas de segurança na produção, operação e atendimento aos clientes. É importante salientar que o suporte da Equipe da Qualidade foi fundamental na disseminação e acompanhamento das diretrizes estabelecidas pela Certificação.
ABSTRACT
Introdução: Atendimentos Presenciais em Hematologia (APH) não estão disponíveis na maioria dos hospitais de Santa Catarina. A solicitação de Teleconsultoria Assíncrona em Hematologia (TAH) por parte do Médico da Atenção Primária (MAP) tem o potencial de ser uma ferramenta valiosa e custo-efetiva para pacientes e profissionais. Apesar de não ter sido avaliada prospectivamente em nossa realidade, TAH pode reduzir tempo por um APH, evitar consultas e deslocamentos desnecessários, e servir como uma ferramenta de educação do MAP em casos que poderiam requerer avaliação na hematologia. Objetivos: Avaliação prospectiva das TAH do Sistema Integrado Catarinense de Telemedicina, entre agosto de 2019 e julho de 2021, com determinação das principais características clínicas que levaram a um encaminhamento para a hematologia. Métodos: Todos os MAP do estado têm acesso ao Sistema Integrado Catarinense de Telemedicina, e as TAH são distribuídas aleatoriamente para os centros de referência em hematologia do estado. O HEMOSC - Joinville é um centro responsável por aproximadamente um quinto das TAH. A definição e classificação de gravidade de anemia da OMS foi utilizada. Para cada consulta, uma única hipótese diagnóstica principal foi estabelecida, baseando-se nos dados fornecidos. Resultados: 790 pacientes acima de 15 anos foram incluídos. A mediana de idade foi de 55 anos (variação interquartil, IQR: 39-70), com 282 pacientes (36%) com 60 anos ou mais. Sessenta por cento dos pacientes eram mulheres (n = 472). Os principais diagnósticos foram: anemia ferropriva (n = 123, 16%), anemia de causa indeterminada (n = 107, 14%), e trombocitopenia inexplicada (n = 102, 13%). Citopenias representaram 499 (63%) diagnósticos. Em 597 casos (76%), o hemograma completo anormal ou testes de coagulação foram a única razão para consulta. Diagnósticos hematológicos foram formulados adequadamente pelos médicos da atenção primária em 140 casos (18%). Hemograma completo foi reportado em 594 casos (75%), sendo a anemia leve o achado mais frequente (n = 188, 32%). A mediana da hemoglobina quando a anemia era o diagnóstico era de 10 g/dL (IQR: 8,7 - 11,1). Ausência de índices de hemácias, contagens diferenciais de leucócitos e contagens de plaquetas foram observadas em 261 (44%), 441 (74%) e 251 (42%) dos casos. O hemograma completo foi coletado 60 dias (ou mais) antes do HTC em 118 dos pacientes (20%) e nenhuma informação de hemograma completo foi fornecida para 196 pacientes (25%), 31% dos quais (n = 60) tinham citopenia como diagnóstico. Hemotransfusões foram relatadas dentro de 60 dias da TAH em 49 pacientes (6%), e avaliação de emergência foi sugerida pelo hematologista para 72 pacientes (9%). Além disso, 190 (24%) pacientes foram encaminhados para APH após a TAH, dos quais 21 (3%), 115 (15%) e 54 (7%) receberam baixa, intermediária e alta prioridade para consulta. Discussão: Durante o período de dois anos relatado, o acesso a TAH preveniu 3 em cada 4 consultas presenciais APH. Isso é especialmente relevante, considerando a necessidade de distanciamento social e os impactos socioeconômicos da Covid-19. Entretanto, interpretações e relatos inadequados de exames laboratoriais, e falha em associar sintomas e histórico cínico aos exames foram achados recorrentes. Conclusões: A interação entre MAP e especialistas é de grande valia e, através da telemedicina, pode beneficiar pacientes, melhorar indicadores de saúde e gerar educação médica continuada em hematologia.
ABSTRACT
Objectives: to evaluate the prevalence of food insecurity and associated factors of students, residents of the Residential Complex of the University of Sao Paulo - CRUSP.
ABSTRACT
Introduction: In-person hematology appointments (IHA) are not available in most hospitals and outpatient centers in the state of Santa Catarina, Brazil. Primary care physician (PCP) based hematology telemedicine consultation (HTC) has the potential of being a valuable and cost-effective tool for patients and PCPs. While it has not been previously assessed in our country, it may avoid unnecessary IHA, which frequently require traveling to major cities, reduce waiting times for an IHA, and advise PCPs on better assessing patients that may need a hematology referral. Methods: Sistema Integrado Catarinense de Telemedicina is a statewide online tool to which all public health system PCPs have access. It enables PCPs to set up asynchronous HTCs that are randomly distributed to reference hematology treatment centers. HEMOSC Joinville is one such center and is responsible for approximately one fifth of all HTCs. We prospectively assessed all HTC requests in non-malignant hematology between August 2019 and July 2021 for main clinical features that prompted a hematology referral. All cases with confirmed or likely diagnosis of hematological malignancy under the 2017 World Health Organization (WHO) classification were excluded. WHO anemia definition and severity classification was observed. Severe neutropenia and thrombocytopenia required counts below 500 and 50,000 per microliter. For every HTC, a single diagnostic hypothesis in hematology (DHH) was established based on patient data provided by the PCP. Results: Seven hundred and ninety consecutive patients aged 15 or older were included. Median age at HTC was 55 years (interquartile range, IQR: 39-70), with 282 patients (36%) aged 60 or more. Sixty percent of patients (n=472) were women, with 26 pregnant women (3%) at a median gestational age of 15 weeks (IQR: 12-21). Major DHHs were iron deficiency anemia (n=123, 16%), anemia of undetermined cause (n=107, 14%) and unexplained thrombocytopenia (n=102, 13%). Cytopenias accounted for 499 (63%) of all DHHs. Abnormal complete blood count (CBC) or coagulation tests were the sole reason for HTC, in the absence of any attributable clinical finding, in 597 cases (76%). DHHs were adequately formulated by PCP in 140 cases (18%). CBC information was provided in 594 cases (75%), with mild anemia (n=188, 32%) being the most frequent finding. Median hemoglobin when anemia was the DHH was 10 g/dL (IQR: 8.7 - 11.1). Absence of red blood cell (RBC) indices, differential leukocyte counts and platelet counts were seen in 261 (44%), 441 (74%) and 251 (42%) cases. CBC was collected in excess of 60 days prior to HTC in 118 patients (20%) and no CBC information was provided for 196 patients (25%), 31% of which (n=60) had a cytopenia as DHH. Blood transfusions were reported within 60 days of HTC in 49 patients (6%), and an emergency department evaluation was suggested by the hematology specialist for 72 patients (9%). One hundred and ninety (24%) patients were referred to an IHA after HTC, of which 21 (3%), 115 (15%) and 54 (7%) received low, intermediate and high priority for an appointment. Conclusions: Over the reported two-year period, HTC has prevented 3 in every 4 IHA in our patient population. This is especially relevant considering the need for social distancing and the socioeconomic impacts of the COVID-19 pandemic. Follow-up analyses of these patients to identify IHA at a later date and the confirmation of hematological diagnosis are in order. This study also uncovers inappropriate CBC interpretation and reporting, and failure to associate clinical symptoms and patient history to laboratory findings, which in turn demands providing PCPs with continued medical education in hematology. [Formula presented] Disclosures: Boettcher: Novartis: Speakers Bureau.
ABSTRACT
Introduction Healthcare workers (HCW) have been reported to be at high risk for several mental health problems due to occupational stress. The outbreak of COVID-19 pandemic in early 2020 raised new concerns about the mental health of HCW workers, which may be affected by new demands and the organization of work. Studies comparing pre-and post-pandemic work environments in health settings are necessary to evaluate the effect of the pandemic on HCWs mental health. Objectives We aimed to investigate the association between occupation stress and depressive symptoms among HCW in a city in northeastern Brazil at the end of 2019, before the COVID-19 outbreak. Methods This is a cross-sectional study with a representative sample of 355 HCW from a city in northeastern Brazil. Occupational stress, based on the demand-control model, was measured by the Job Content Questionnaire (JCQ), and depressive symptoms were evaluated by the Patient Health Questionnaire (PHQ-9). Poisson regressions were used to estimate prevalence ratios (PR) and to analyse associations of interest. Results The prevalence of depressive symptoms (PHQ-9 > 9) was 22.4%. Occupational stress was strongly associated with the outcome. In the crude analyses, the prevalence of depression symptoms among workers eposed to high job strain was 3.54 (95% CI: 1.60-6.90) times that of those with low strain. After adjustment for sex, age and income, the prevalence ratio remained highly significant (PR=3.34;95%CI: 1.80-6.18). Conclusions Occupational stress was a strong risk factor for depressive symptoms in a pre-pandemic scenario. The prevalence of depressive symptoms is expected to increase during the pandemic. Assessing occupational stress and depression during follow-up over the next few years may elucidate the impact of the pandemic on work processes and on HCWs mental health.
ABSTRACT
The year of 2020 was greatly affected by COVID-19 pandemic, it was necessary to change the work routine, study and social life and adapt to the new world scenario that was suddenly established. The technology, and especially the software, contributed a lot for these changes to be managed and carried out efficiently, mainly in the scope of communication and information. To prevent the pandemic from advancing, protective measures were taken by the state and federal governments, including recommendations for social distancing, wearing masks in a public environment and avoiding people in a feverish state, so the world policed itself and tried to comply with the new guidelines. However, a visually impaired person would not be able to comply with these determinations, how could he know if the person in front of him is wearing a mask or not, or even far enough, not respecting the recommended minimum distance of 1.5 m, or even checking the temperature of someone entering the same environment as him. Motivated by this problem, this research was initiated, with the goal of the development of a case to be coupled to an eyeglass, with processors and sensors, that will detect if the person in front is wearing a face mask, is 1.5 m far and in a possible feverish state, being processed by an Artificial Intelligence software with 95% accuracy. The functional status of the project was successfully executed, the results were satisfactory, with improvements in terms of embedded technology and tests on the impaired resulted in hope and excitement for them. © 2021, Springer Nature Switzerland AG.
ABSTRACT
Background The COVID-19 pandemic appears to have contributed to change in eating habits for a significant part of the Portuguese population. The increase in the snacks consumption during the confinement period was reported by almost a third of the population. Often the snacks chosen are ultra-processed foods: industrial formulations that include excess of sugar, oils, fats, salt, and additives, antioxidant, stabilizers and preservatives substances in their ingredients. Excessive ultra-processed food consumption has been associated with worse health indicators. Objectives To develop informative educational material about ultra-processed foods and their health risks to be available to the general Portuguese population, and thus to promote food and nutrition literacy. Results The development of this new tool started in September 2020 and in April 2021 the booklet was approved by the UPPER Project team to be made available through digital media (cell phone, computer, laptop and tablet) or print. The booklet contains 33 pages with illustrative images and simple and didactic language. It is focused in seven main topics: “What are ultra-processed foods?”, “Which are they?”, “How to recognize them when purchasing?”, “What are worth for?”, “What is the relationship with health?”, and “What foods to choose?”. A short video with 2 minutes duration, summarizing and explaining the booklet, was also produced. The booklet impact will be piloted in a school intervention project that has been designed and submitted for ethical approval. Conclusions The developed booklet and explanatory video are didactic materials in simple language to achieve all general Portuguese population. Key messages The booklet is an instrument intending to improve literacy in ultra-processed foods. The booklet is a tool that can be used in health promotion programs and public policies in food and nutrition.
ABSTRACT
Deaf people are a considerable part of the world population and communicate naturally using sign languages. However, although many countries adopt their sign language as an official language, there are linguistics barriers to accessing fundamental rights, especially access to health services, even more critical situation in the midst of the COVID-19 crisis. This situation has been the focus of some government policies that oblige essential service providers to provide sign language interpreters to assist Deaf people. However, this type of solution has high operating costs, mainly to serve the entire Deaf community in all environments. These setbacks motivate the investigation of methodologies and automated tools to support this type of problem. In this paper, we address this problem by proposing two-stream model for the recognition of the Brazilian Sign Language (Libras) in the health context. The proposed solution does not use any additional capture sensor or hardware, being entirely base on images or sequences of images (videos). The results show that the solution is able to recognize the Libras signs in the test dataset reasonably well, achieved an average accuracy of approximately 96,12% considering a scenario where the interpreter used in the test set was not used in the training set, which shows that there are good evidence that it can assist in the communication process with Deaf people. Besides, an additional contribution of this paper is the introduction of a new dataset in the Brazilian sign language (Libras) containing 5000 videos of 50 signs in the health context, which may assist the development and research of other solutions. © 2020 ACM.
ABSTRACT
Objective: To analyze the spatial-temporal distribution of COVID-19 in the state of Piauí. Method: Ecological, retrospective study, with data available from the COVID-19 Epidemiological Panel - Piauí. A time series of cases and deaths accumulated monthly was constructed and incidence, mortality and lethality rates were calculated and choropleth maps were constructed using Quantum GIS, version 2.18.6. Results: In March 2020, three cases were recorded, without death, reaching September 2020 with 90,370 cases and 2,037 deaths, with a slight reduction in the growth of rates from August. Teresina presented the second lowest incidence coefficient of the state, the second highest mortality coefficient and the highest lethality. Conclusion: There was a wide growth of the pandemic in the state, especially until August 2020, with lethality within the expected, and the spatial distribution of cases and deaths concentrated in the capital and surroundings, evidencing the need for strong preventive measures. © 2021 Universidade Federal da Bahia. All rights reserved.
ABSTRACT
INTRODUCTION: A marked proportion of patients with obesity has insulin resistance and hyperactivity of the renin-angiotensin-aldosterone system, which may be related to the worse results caused by SARS-CoV 2. In addition, the angiotensin 2-converting enzyme has greater expression in adipose tissue when compared to the lung, being susceptible to the entry of the virus in the adipocytes making it an important viral reservoir allowing the spread to too many organs. OBJECTIVE: To identify whether obesity can be a more serious predictor and worse prognosis for Coronavirus Disease 2019 (COVID-19). MATERIALS AND METHODS: Systematic review under the code CRD42020200617 with observational studies through the PubMed databases, the VHL Regional Portal, SciELO, Science Direct and Cochrane, and manual searches using the “Prognosis” OR “Patient Acuity” AND “ Coronavirus Infections " AND " Obesity ". Observational studies that assess the impact of COVID-19 in common with obesity of both sexes that assess a score ≥7 on the Newcastle-Ottawa scale were included. RESULTS: 9 studies were included, totaling a sample of 179,047 adult patients aged 18 to 80 years, with a minimum BMI <24 kg / m2 and a maximum> 35 kg / m2. It was found that with obesity, he wishes to present an increase in the admission rates for acute and mandatory care, invasive mechanical necessity IMV), pneumonia and develop severe COVID-19, thus increasing their hospital stay. CONCLUSION: Individuals with obesity develop greater severity and worse prognosis for COVID-19, since there is an increase in admission rates for acute and mandatory care, need for IMV, length of hospital stay, severity and lethality. © 2020, BAHIANA - School of Medicine and Public Health. All rights reserved.
ABSTRACT
Objective: To analyze COVID-19 vaccine acceptance among people diagnosed with flu-like illness. Methods: This is a cross-sectional study with a random sample consisting of 454 participants. Data were collected from March to August 2020, in two stages: in the first, data available in the information systems were collected, using an instrument adapted from the investigation form of flu-like illness suspected by COVID-19, and in the second stage, primary data was collected from the participant through a telephone call. For the bivariate analysis, Pearson's chi-square test was performed (chi(2)).To explain the joint effect of predictor variables on the dependent variable, Multiple Logistics Regression (MRL) with adjusted Odds Ratio (aOR) was used. Results: Participants most willing to receive a COVID-19 vaccine are those who learned about it on social media (aOR = 4.56, 95% CI: 1.77-11.72) and on newspapers and TV (aOR =2.74. 95%CI= 1.07-7.04). Conclusion: Having information about the vaccine, whether through social networks or newspapers and TV, increased the predisposition to take it. Thus, it is necessary to intensify effective information about the benefits of vaccines that will be approved by the Brazilian National Health Regulatory Agency (Agencia Nacional de Vigilancia Sanitaria - ANVISA).